Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
about
Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patientsRole of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand.
P2860
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
@ast
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
@en
type
label
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
@ast
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
@en
prefLabel
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
@ast
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
@en
P2860
P356
P1433
P1476
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?
@en
P2093
Ormerod LP
P2860
P356
10.1136/THX.54.2008.S42
P407
P478
54 Suppl 2
P577
1999-08-01T00:00:00Z